Variant report
Variant | nsv982313 |
---|---|
Chromosome Location | chr9:86683194-86695733 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:33)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:33 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr9:86691048-86691355 | K562 | blood: | n/a | n/a |
2 | BHLHE40 | chr9:86691087-86691287 | HepG2 | liver: | n/a | n/a |
3 | CBX3 | chr9:86685563-86685798 | K562 | blood: | n/a | n/a |
4 | CHD2 | chr9:86685589-86685878 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | CHD2 | chr9:86685570-86685904 | HepG2 | liver: | n/a | n/a |
6 | CHD2 | chr9:86685568-86685955 | K562 | blood: | n/a | n/a |
7 | CTCF | chr9:86694073-86694138 | Lung_OC | lung: | n/a | n/a |
8 | E2F6 | chr9:86685566-86685766 | K562 | blood: | n/a | n/a |
9 | E2F6 | chr9:86685425-86685924 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | ELK1 | chr9:86683861-86684157 | K562 | blood: | n/a | n/a |
11 | FOXA1 | chr9:86693806-86694037 | T-47D | breast: | n/a | n/a |
12 | FOXA1 | chr9:86693841-86693994 | T-47D | breast: | n/a | n/a |
13 | GATA3 | chr9:86693300-86693423 | SH-SY5Y | brain: | n/a | n/a |
14 | JUND | chr9:86695042-86695092 | K562 | blood: | n/a | n/a |
15 | MAX | chr9:86685555-86685901 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | MAX | chr9:86685511-86685818 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | MAX | chr9:86685480-86685785 | K562 | blood: | n/a | n/a |
18 | MAX | chr9:86685574-86685708 | K562 | blood: | n/a | n/a |
19 | MAX | chr9:86685538-86685833 | HepG2 | liver: | n/a | n/a |
20 | POLR2A | chr9:86686933-86686956 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | RCOR1 | chr9:86695042-86695181 | K562 | blood: | n/a | n/a |
22 | SPI1 | chr9:86689964-86690178 | GM12878 | blood: | n/a | n/a |
23 | SPI1 | chr9:86694951-86695272 | HL-60 | blood: | n/a | n/a |
24 | SPI1 | chr9:86689939-86690168 | GM12891 | blood: | n/a | n/a |
25 | SPI1 | chr9:86694906-86695261 | HL-60 | blood: | n/a | n/a |
26 | SPI1 | chr9:86695008-86695211 | K562 | blood: | n/a | n/a |
27 | SRF | chr9:86683767-86684183 | H1-hESC | embryonic stem cell: | n/a | chr9:86683964-86683982 |
28 | SRF | chr9:86683720-86684200 | ECC-1 | luminal epithelium: | n/a | chr9:86683964-86683982 |
29 | SRF | chr9:86683799-86684124 | H1-hESC | embryonic stem cell: | n/a | chr9:86683964-86683982 |
30 | SRF | chr9:86683723-86684314 | MCF-7 | breast: | n/a | chr9:86683964-86683982 |
31 | SRF | chr9:86683871-86684011 | HepG2 | liver: | n/a | chr9:86683964-86683982 |
32 | USF1 | chr9:86691051-86691311 | K562 | blood: | n/a | n/a |
33 | ZBTB33 | chr9:86685537-86685951 | K562 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RMI1-2 | chr9:86692821-86693002 | ENSG00000227463.2 |
2 | lnc-RMI1-2 | chr9:86690343-86690763 | ENSG00000227463.2 |
3 | lnc-RMI1-8 | chr9:86693499-86693772 | NONHSAT132772 |
4 | lnc-RMI1-2 | chr9:86690576-86690763 | ENSG00000227463.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000270166 | TF binding region |
ENSG00000165119 | chromatin interactions |
ENSG00000178966 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35470295 | chr9:86683197-86683198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs13288669 | chr9:86683233-86683234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182282967 | chr9:86683271-86683272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112348594 | chr9:86683332-86683333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551683830 | chr9:86685608-86685609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570034748 | chr9:86685678-86685679 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs556579396 | chr9:86685710-86685711 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs4877819 | chr9:86685730-86685731 | Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs545709445 | chr9:86685731-86685732 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs567704765 | chr9:86685767-86685768 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs534853012 | chr9:86685768-86685769 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs568053705 | chr9:86685809-86685810 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs553323075 | chr9:86685823-86685824 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs563074590 | chr9:86685834-86685835 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs578096975 | chr9:86685842-86685843 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs545304252 | chr9:86685871-86685872 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs557267396 | chr9:86685914-86685915 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs575628582 | chr9:86685921-86685922 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs542806570 | chr9:86685946-86685947 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs113674190 | chr9:86685977-86685978 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs199999647 | chr9:86686001-86686002 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs528177815 | chr9:86686043-86686044 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs371251461 | chr9:86686216-86686217 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs564874644 | chr9:86686248-86686249 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs72749164 | chr9:86686274-86686275 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs550176247 | chr9:86686352-86686353 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs572700453 | chr9:86686396-86686397 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs200932044 | chr9:86686436-86686437 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs569974432 | chr9:86686442-86686443 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs188262612 | chr9:86686461-86686462 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs531113137 | chr9:86686502-86686503 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs549552262 | chr9:86686592-86686593 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs567804382 | chr9:86686593-86686594 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs535104172 | chr9:86686594-86686595 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs553221650 | chr9:86686595-86686596 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs571792345 | chr9:86686596-86686597 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs148492912 | chr9:86686715-86686716 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs557403837 | chr9:86686716-86686717 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs575604183 | chr9:86686843-86686844 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs143730540 | chr9:86686852-86686853 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs541236118 | chr9:86686864-86686865 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs572979735 | chr9:86686913-86686914 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs11559389 | chr9:86686916-86686917 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs371083007 | chr9:86686930-86686931 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs140697554 | chr9:86686953-86686954 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs373710012 | chr9:86686960-86686961 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs532086793 | chr9:86687034-86687035 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs113271053 | chr9:86687178-86687179 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs562191140 | chr9:86687210-86687211 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs531100778 | chr9:86687326-86687327 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:86682800-86683400 | Enhancers | Brain Germinal Matrix | brain |
2 | chr9:86685600-86685800 | Enhancers | Pancreas | Pancrea |
3 | chr9:86685800-86687600 | Weak transcription | Pancreas | Pancrea |
4 | chr9:86687600-86688000 | Enhancers | Fetal Intestine Large | intestine |
5 | chr9:86687600-86688000 | Enhancers | Pancreas | Pancrea |
6 | chr9:86688000-86688400 | Enhancers | Stomach Mucosa | stomach |
7 | chr9:86688000-86690800 | Weak transcription | Fetal Intestine Large | intestine |
8 | chr9:86690800-86691400 | Enhancers | Fetal Intestine Large | intestine |
9 | chr9:86690800-86691800 | Enhancers | Colonic Mucosa | Colon |
10 | chr9:86690800-86691800 | Enhancers | Fetal Intestine Small | intestine |
11 | chr9:86690800-86692000 | Enhancers | Sigmoid Colon | Sigmoid Colon |
12 | chr9:86691000-86691800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
13 | chr9:86691200-86692000 | Enhancers | Duodenum Mucosa | Duodenum |
14 | chr9:86693600-86693800 | Enhancers | Adipose Nuclei | Adipose |
15 | chr9:86693600-86694400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr9:86693800-86694400 | Weak transcription | Adipose Nuclei | Adipose |
17 | chr9:86694400-86696000 | Enhancers | Adipose Nuclei | Adipose |
18 | chr9:86695000-86695200 | Enhancers | Hela-S3 | cervix |
19 | chr9:86695000-86695200 | Bivalent Enhancer | HepG2 | liver |
20 | chr9:86695600-86696000 | Enhancers | Spleen | Spleen |